Kah Meng Lim

Chief Executive Officer en COMPASS VENTURE INC. .

Fortuna: 64 800 $ al 30/11/2023

52 años

Consumer Services

Health Services

Perfil

Kah Meng Lim is the founder of Gene Oasis Pte Ltd.
He is currently the Chief Executive Officer & Director at Compass Venture, Inc., Chief Executive Officer at Zenzic Labs Pte Ltd., Chief Executive Officer at NGF Bioenterprise Pte Ltd., Director at GDX Corp., Independent Non-Executive Director at Singapore Paincare Holdings Ltd., Director at CanniOasis Pte Ltd., and Director at Betalife Pte Ltd.
Dr. Lim previously worked as an Associate Professor at Tianjin University from 2014 to 2017.
He received his doctorate degree from Yong Loo Lin School of Medicine in 2001.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
COMPASS VENTURE, INC. 7.08%	26/10/2022	400 000 ( 7.08% )	64 800 $	30/11/2023

Cargos activos de Kah Meng Lim

Empresas	Cargo	Inicio
COMPASS VENTURE INC.	Chief Executive Officer	02/01/2019
SINGAPORE PAINCARE HOLDINGS LIMITED	Director/Board Member	05/03/2021
Zenzic Labs Pte Ltd.	Chief Executive Officer	01/01/2019
NGF Bioenterprise Pte Ltd.	Chief Executive Officer	01/01/2017
GDX Corp.	Director/Board Member	01/01/2019